OctoPlus N.V. has opened its business development office in Boston to better serve clients and expand its business in North America. The office will be operated by OctoPlus, Inc., a wholly owned subsidiary of OctoPlus N.V., and will support drug development activities as well as drug formulation and manufacturing business. The company has appointed Michiel Lodder, Ph.D., to the role of director business development, North America. Dr. Lodder was previously manager business development and p...